RAD6 promotes chemoresistance in ovarian cancer

Mortality in ovarian cancer is predominantly due to acquired chemoresistance and tumor recurrence. UBIQUITIN CONJUGATING ENZYME E2 or RAD6 expression increases in cell lines and patient tumors in response to platinum-based chemotherapy and promotes both activation of DNA damage response pathways and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Cell Oncol
Egile Nagusiak: Clark, David W., Mani, Chinnadurai, Palle, Komaraiah
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2017
Gaiak:
Author's Views
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5791863/
https://ncbi.nlm.nih.gov/pubmed/29404391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2017.1392403
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak